The melanoma revolution: From UV carcinogenesis to a new era in therapeutics

Science

Volumn 346, Issue 6212, 2014, Pages 945-949

  Lo, Jennifer A ^a   Fisher, David E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TRANSCRIPTION FACTOR;

CANCER; CARCINOGEN; DISEASE INCIDENCE; DISEASE TREATMENT; GENOMICS; IMMUNIZATION; MELANISM; PARADIGM SHIFT; PUBLIC HEALTH; RISK FACTOR; ULTRAVIOLET RADIATION;

CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CELL CYCLE REGULATION; CELL PROLIFERATION; EPIGENETICS; GENOMICS; HUMAN; MELANOCYTE; MELANOMA; MOLECULARLY TARGETED THERAPY; PATHOGENESIS; RADIATION CARCINOGENESIS; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; TUMOR GENE; CARCINOGENESIS; DRUG APPROVAL; GENETIC EPIGENESIS; GENETICS; IMMUNOTHERAPY; MUTATION; NEOPLASMS, RADIATION-INDUCED; PATHOLOGY; SKIN NEOPLASMS; SUNLIGHT; ULTRAVIOLET RADIATION;

CARCINOGENESIS; DRUG APPROVAL; EPIGENESIS, GENETIC; HUMANS; IMMUNOTHERAPY; MELANOCYTES; MELANOMA; MOLECULAR TARGETED THERAPY; MUTATION; NEOPLASMS, RADIATION-INDUCED; SKIN NEOPLASMS; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 84911866508     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1253735     Document Type: Review

References (75)

1. R. Siegel, J. Ma, Z. Zou, A. Jemal, CA Cancer J. Clin. 64, 9-29 (2014)
2. J. Y. Lin, D. E. Fisher, Nature 445, 843-850 (2007)
3. R. Cui et al., Cell 128, 853-864 (2007)
4. D. C. Whiteman, C. A. Whiteman, A. C. Green, Cancer Causes Control 12, 69-82 (2001)
5. M. Boniol, P. Autier, P. Boyle, S. Gandini, BMJ 345, e4757 (2012)
6. L. Garibyan, D. E. Fisher, Curr. Oncol. Rep. 12, 319-326 (2010)
7. M. R. Zaidi et al., Nature 469, 548-553 (2011)
8. T. Bald et al., Nature 507, 109-113 (2014)
9. J. L. Rees, Annu. Rev. Genet. 37, 67-90 (2003)
10. D. Mitra et al., Nature 491, 449-453 (2012)
11. C. J. Hussussian et al., Nat. Genet. 8, 15-21 (1994)
12. D. T. Bishop et al., Nat. Genet. 41, 920-925 (2009)
13. H. Davies et al., Nature 417, 949-954 (2002)
14. E. D. Pleasance et al., Nature 463, 191-196 (2010)
15. M. S. Stark et al., Nat. Genet. 44, 165-169 (2011)
16. E. Hodis et al., Cell 150, 251-263 (2012)
17. M. Krauthammer et al., Nat. Genet. 44, 1006-1014 (2012)
18. M. S. Lawrence et al., Nature 505, 495-501 (2014)
19. L. B. Alexandrov et al., Nature 500, 415-421 (2013)
20. E. Kvam, R. M. Tyrrell, J. Invest. Dermatol. 113, 209-213 (1999)
21. F. W. Huang et al., Science 339, 957-959 (2013)
22. A. Viros et al., Nature 511, 478-482 (2014)
23. A. M. Menzies et al., Clin. Cancer Res. 18, 3242-3249 (2012)
24. J. A. Curtin et al., N. Engl. J. Med. 353, 2135-2147 (2005)
25. A. C. Green, G. M. Williams, V. Logan, G. M. Strutton, J. Clin. Oncol. 29, 257-263 (2011)
26. A. P. Albino, R. Le Strange, A. I. Oliff, M. E. Furth, L. J. Old, Nature 308, 69-72 (1984)
27. J. M. Stahl et al., Cancer Res. 64, 7002-7010 (2004)
28. M. Stark, N. Hayward, Cancer Res. 67, 2632-2642 (2007)
29. K. A. Furge et al., Proc. Natl. Acad. Sci. U.S.A. 98, 10722-10727 (2001)
30. N. Bardeesy et al., Mol. Cell. Biol. 25, 4176-4188 (2005)
31. J. A. Curtin, K. Busam, D. Pinkel, B. C. Bastian, J. Clin. Oncol. 24, 4340-4346 (2006)
32. O. Maertens et al., Cancer Discov. 3, 338-349 (2013)
33. C. D. Van Raamsdonk et al., Nature 457, 599-602 (2009)
34. H. Tsao, L. Chin, L. A. Garraway, D. E. Fisher, Genes Dev. 26, 1131-1155 (2012)
35. L. A. Garraway et al., Nature 436, 117-122 (2005)
36. S. Yokoyama et al., Nature 480, 99-103 (2011)
37. G. M. Kraehn et al., Br. J. Cancer 84, 72-79 (2001)
38. D. L. Rimm, K. Caca, G. Hu, F. B. Harrison, E. R. Fearon, Am. J. Pathol. 154, 325-329 (1999)
39. J. W. Harbour et al., Science 330, 1410-1413 (2010)
40. K. T. Flaherty et al., N. Engl. J. Med. 363, 809-819 (2010)
41. P. B. Chapman et al., N. Engl. J. Med. 364, 2507-2516 (2011)
42. A. Hauschild et al., Lancet 380, 358-365 (2012)
43. S. J. Heidorn et al., Cell 140, 209-221 (2010)
44. F. Su et al., N. Engl. J. Med. 366, 207-215 (2012)
45. K. T. Flaherty et al., N. Engl. J. Med. 367, 1694-1703 (2012)
46. K. T. Flaherty et al., N. Engl. J. Med. 367, 107-114 (2012)
47. R. Haq et al., Proc. Natl. Acad. Sci. U.S.A. 110, 4321-4326 (2013)
48. K. H. T. Paraiso et al., Cancer Res. 71, 2750-2760 (2011)
49. K. S. M. Smalley et al., Mol. Cancer Ther. 7, 2876-2883 (2008)
50. C. M. Emery et al., Proc. Natl. Acad. Sci. U.S.A. 106, 20411-20416 (2009)
51. C. M. Johannessen et al., Nature 504, 138-142 (2013)
52. P. I. Poulikakos et al., Nature 480, 387-390 (2011)
53. R. Nazarian et al., Nature 468, 973-977 (2010)
54. S. R. Whittaker et al., Cancer Discov 3, 350-362 (2013)
55. E. M. Van Allen et al., Cancer Discov 4, 94-109 (2014)
56. H. Shi et al., Nat. Commun. 3, 724 (2012)
57. W. H. Cole, T. C. Everson, Ann. Surg. 144, 366-383 (1956)
58. M. H. Greene, T. I. Young, W. H. Clark Jr., Lancet 317, 1196-1199 (1981)
59. D. Morton, F. R. Eilber, R. A. Malmgren, W. C. Wood, Surgery 68, 158-163 (1970)
60. C. G. Clemente et al., Cancer 77, 1303-1310 (1996)
61. M. B. Atkins et al., J. Clin. Oncol. 17, 2105-2116 (1999)
62. S. A. Rosenberg et al., Clin. Cancer Res. 17, 4550-4557 (2011)
63. A. H. Sharpe, Immunol. Rev. 229, 5-11 (2009)
64. T. F. Gajewski, H. Schreiber, Y. X. Fu, Nat. Immunol. 14, 1014-1022 (2013)
65. F. S. Hodi et al., N. Engl. J. Med. 363, 711-723 (2010)
66. S. L. Topalian et al., N. Engl. J. Med. 366, 2443-2454 (2012)
67. O. Hamid et al., N. Engl. J. Med. 369, 134-144 (2013)
68. J. D. Wolchok et al., N. Engl. J. Med. 369, 122-133 (2013)
69. A. Boni et al., Cancer Res. 70, 5213-5219 (2010)
70. A. Ribas, F. S. Hodi, M. Callahan, C. Konto, J. Wolchok, N. Engl. J. Med. 368, 1365-1366 (2013)
71. M. R. Albert, K. G. Ostheimer, J. Am. Acad. Dermatol. 47, 930-937 (2002)
72. C. E. Mosher, S. Danoff-Burg, Arch. Dermatol. 146, 412-417 (2010)
73. G. L. Fell, K. C. Robinson, J. Mao, C. J. Woolf, D. E. Fisher, Cell 157, 1527-1534 (2014)
74. D. Mayer, A. Layman, J. Carlson, J. Am. Acad. Dermatol. 66, e9-e10 (2012)
75. P. F. Robbins et al., Nat. Genet. 19, 747-752 (2013)